{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:17Z","timestamp":1781632457697,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Colorectal cancer is the third most common cancer and the second leading cause of cancer-related deaths worldwide, according to GLOBOCAN 2022. Lymph node metastasis is a well-recognized prognostic factor in colorectal cancer. While the relationship between ABO blood group, Rhesus (Rh) type, and lymphatic spread has been studied in other gastrointestinal tumors, limited research exists on colorectal cancer. This study primarily aimed to investigate the association between lymph node metastasis and ABO blood group, as well as the relationship between microsatellite instability (MSI) and ABO blood group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>. A retrospective observational cohort study was conducted, including all patients who underwent elective colorectal resections with curative intent for malignant colorectal tumors between March 2017 and March 2023. Eligible patients had documented ABO blood group and Rh type, along with pathology reports from surgical specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>. The study included 270 patients, with a median age of 74.5 years-old. The cohort was predominantly female (50.4%). Lymph node metastasis was observed in 156 patients (57.7%). A binary logistic regression model identified factors associated with lymphatic spread: rectal tumor location (OR: 3.85, 95% CI: 1.14\u201315.60), poorly differentiated tumors (OR: 6.84, 95% CI: 1.37\u201353.80), invasion depth T3 (OR: 4.88, 95% CI: 1.72\u201316.90) and T4 (OR: 16.20, 95% CI: 4.78\u201365.60), and extramural vein invasion (OR: 7.17, 95% CI: 1.37\u201353.80). Notably, the AB blood group (OR: 0.12, 95% CI: 0.01\u20130.65) was associated with a lower likelihood of lymph node metastasis, suggesting a potential protective effect. A separate binary logistic regression analysis evaluating factors related to MSI found no statistically significant associations, including for ABO blood group and Rh antigen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that the AB blood group is associated with a reduced likelihood of lymph node metastasis compared to other blood groups. However, the existing literature on the relationship between blood group and lymph node metastasis is inconsistent. Further research is necessary to clarify the prognostic role of ABO blood group in colorectal cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-025-04179-1","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:58:09Z","timestamp":1769518689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relationship between ABO blood group and lymph node metastasis in colon cancer: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1929-2299","authenticated-orcid":false,"given":"Camilo","family":"Ram\u00edrez-Giraldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7560-551X","authenticated-orcid":false,"given":"Antonio","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"3","key":"4179_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"9927","key":"4179_CR2","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490\u2013502.","journal-title":"Lancet"},{"issue":"1","key":"4179_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08941939.2017.1369605","volume":"32","author":"G Li Destri","year":"2019","unstructured":"Li Destri G, Barchitta M, Pesce A, Latteri S, Bosco D, Di Cataldo A, et al. Predictive value of the number of harvested lymph nodes and cut-off for lymph node ratio in the prognosis of stage II and III colorectal cancer patients. J Invest Surg. 2019;32(1):1\u20137. https:\/\/doi.org\/10.1080\/08941939.2017.1369605.","journal-title":"J Invest Surg"},{"issue":"2","key":"4179_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamcollsurg.2013.04.018","volume":"217","author":"DM Hari","year":"2013","unstructured":"Hari DM, Leung AM, Lee JH, Sim MS, Vuong B, Chiu CG, et al. AJCC cancer staging manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? J Am Coll Surg. 2013;217(2):181\u201390. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2013.04.018.","journal-title":"J Am Coll Surg"},{"key":"4179_CR5","doi-asserted-by":"publisher","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(10):1291\u2013305. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.022.","DOI":"10.1016\/j.annonc.2020.06.022"},{"issue":"33","key":"4179_CR6","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1200\/JCO.24.00393","volume":"42","author":"J Lu","year":"2024","unstructured":"Lu J, Xing J, Zang L, Zhang C, Xu L, Zhang G, et al. Extent of lymphadenectomy for surgical management of right-sided colon cancer: the randomized phase III RELARC trial. J Clin Oncol. 2024;42(33):3957\u201366. https:\/\/doi.org\/10.1200\/JCO.24.00393.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4179_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canep.2014.12.006","volume":"39","author":"W Sun","year":"2015","unstructured":"Sun W, Wen CP, Lin J, Wen C, Pu X, Huang M, Tsai MK, Tsao CK, Wu X, Chow WH. ABO blood types and cancer risk\u2013a cohort study of 339,432 subjects in Taiwan. Cancer Epidemiol. 2015;39(2):150\u20136. https:\/\/doi.org\/10.1016\/j.canep.2014.12.006.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"4179_CR8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3892\/etm.2016.3347","volume":"12","author":"W Zhang","year":"2016","unstructured":"Zhang W, Xu Q, Zhuang Y, Chen Y. Novel association of soluble intercellular adhesion molecule 1 and soluble P-selectin with the ABO blood group in a Chinese population. Exp Ther Med. 2016;12(2):909\u201314. https:\/\/doi.org\/10.3892\/etm.2016.3347.","journal-title":"Exp Ther Med"},{"issue":"1","key":"4179_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12029-023-00958-9","volume":"55","author":"BB Karaoglan","year":"2024","unstructured":"Karaoglan BB, Akyol C, Unal AE, Kuzu A, Sava\u015f B, Utkan G. Relationship between ABO blood group and microsatellite instability in colorectal cancer: a retrospective single-center study. J Gastrointest Cancer. 2024;55(1):281\u20136. https:\/\/doi.org\/10.1007\/s12029-023-00958-9.","journal-title":"J Gastrointest Cancer"},{"key":"4179_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejca.2022.07.020","volume":"175","author":"J Taieb","year":"2022","unstructured":"Taieb J, Svrcek M, Cohen R, Basile D, Tougeron D, Phelip JM. Deficient mismatch repair\/microsatellite unstable colorectal cancer: diagnosis, prognosis and treatment. Eur J Cancer. 2022;175:136\u201357. https:\/\/doi.org\/10.1016\/j.ejca.2022.07.020.","journal-title":"Eur J Cancer"},{"key":"4179_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-019-1091-8","volume":"20","author":"K Li","year":"2020","unstructured":"Li K, Luo H, Huang L, Luo H, Zhu X. Microsatellite instability: a review of what the oncologist should know. Cancer Cell Int. 2020;20:16. https:\/\/doi.org\/10.1186\/s12935-019-1091-8.","journal-title":"Cancer Cell Int"},{"issue":"9596","key":"4179_CR12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"20","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;20(9596):1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"8","key":"4179_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3109\/00365528608996408","volume":"21","author":"TB Halvorsen","year":"1986","unstructured":"Halvorsen TB. ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases. Scand J Gastroenterol. 1986;21(8):979\u201383. https:\/\/doi.org\/10.3109\/00365528608996408.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"4179_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/bjc.1979.46","volume":"39","author":"P Hersey","year":"1979","unstructured":"Hersey P, Edwards A, Trilivas C, Shaw H, Milton GW. Relationship of natural killer-cell activity to rhesus antigens in man. Br J Cancer. 1979;39(3):234\u201340. https:\/\/doi.org\/10.1038\/bjc.1979.46.","journal-title":"Br J Cancer"},{"issue":"1","key":"4179_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF02050293","volume":"36","author":"G Slater","year":"1993","unstructured":"Slater G, Itzkowitz S, Azar S, Aufses AH Jr. Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer. Dis Colon Rectum. 1993;36(1):5\u20137. https:\/\/doi.org\/10.1007\/BF02050293.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"4179_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/bjc.2014.302","volume":"111","author":"X Cao","year":"2014","unstructured":"Cao X, Wen ZS, Sun YJ, Li Y, Zhang L, Han YJ. Prognostic value of ABO blood group in patients with surgically resected colon cancer. Br J Cancer. 2014;111(1):174\u201380. https:\/\/doi.org\/10.1038\/bjc.2014.302.","journal-title":"Br J Cancer"},{"issue":"1","key":"4179_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1432-1033.1980.tb04414.x","volume":"104","author":"J Finne","year":"1980","unstructured":"Finne J. Identification of the blood-group ABH-active glycoprotein components of human erythrocyte membrane. Eur J Biochem. 1980;104(1):181\u20139. https:\/\/doi.org\/10.1111\/j.1432-1033.1980.tb04414.x.","journal-title":"Eur J Biochem"},{"key":"4179_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cca.2015.02.016","volume":"444","author":"M Franchini","year":"2015","unstructured":"Franchini M, Bonfanti C. Evolutionary aspects of ABO blood group in humans. Clin Chim Acta. 2015;444:66\u201371. https:\/\/doi.org\/10.1016\/j.cca.2015.02.016.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"4179_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1023\/a:1007173722426","volume":"17","author":"N Fujitani","year":"2000","unstructured":"Fujitani N, Liu Y, Toda S, Shirouzu K, Okamura T, Kimura H. Expression of H type 1 antigen of ABO histo-blood group in normal colon and aberrant expressions of H type 2 and H type 3\/4 antigens in colon cancer. Glycoconj J. 2000;17(5):331\u20138. https:\/\/doi.org\/10.1023\/a:1007173722426.","journal-title":"Glycoconj J"},{"issue":"9","key":"4179_CR20","first-page":"4499","volume":"45","author":"M Yuan","year":"1985","unstructured":"Yuan M, Itzkowitz SH, Palekar A, Shamsuddin AM, Phelps PC, Trump BF, Kim YS. Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonic tissue. Cancer Res. 1985;45(9):4499\u2013511.","journal-title":"Cancer Res"},{"issue":"1","key":"4179_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0304-4165(99)00183-x","volume":"1473","author":"S Hakomori","year":"1999","unstructured":"Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta. 1999;1473(1):247\u201366. https:\/\/doi.org\/10.1016\/s0304-4165(99)00183-x.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4179_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1600-0463.2000.d01-1.x","volume":"108","author":"V Ravn","year":"2000","unstructured":"Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS. 2000;108(1):1\u201328. https:\/\/doi.org\/10.1034\/j.1600-0463.2000.d01-1.x.","journal-title":"APMIS"},{"issue":"6","key":"4179_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/glycob\/9.6.607","volume":"9","author":"S Nishihara","year":"1999","unstructured":"Nishihara S, Hiraga T, Ikehara Y, Kudo T, Iwasaki H, Morozumi K, Akamatsu S, Tachikawa T, Narimatsu H. Molecular mechanisms of expression of Lewis b antigen and other type I Lewis antigens in human colorectal cancer. Glycobiology. 1999;9(6):607\u201316. https:\/\/doi.org\/10.1093\/glycob\/9.6.607.","journal-title":"Glycobiology"},{"issue":"7","key":"4179_CR24","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/labinvest.3700268","volume":"85","author":"Y Chihara","year":"2005","unstructured":"Chihara Y, Sugano K, Kobayashi A, Kanai Y, Yamamoto H, Nakazono M, Fujimoto H, Kakizoe T, Fujimoto K, Hirohashi S, Hirao Y. Loss of blood group A antigen expression in bladder cancer caused by allelic loss and\/or methylation of the ABO gene. Lab Invest. 2005;85(7):895\u2013907. https:\/\/doi.org\/10.1038\/labinvest.3700268.","journal-title":"Lab Invest"},{"issue":"15","key":"4179_CR25","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1002\/1097-0142(19910615)67:12<3042::aid-cncr2820671219>3.0.co;2-l","volume":"67","author":"K Tauchi","year":"1991","unstructured":"Tauchi K, Kakudo K, Machimura T, Makuuchi H, Mitomi T. Immunohistochemical studies of blood group-related antigens in human superficial esophageal carcinomas. Cancer. 1991;67(15):3042\u201350. https:\/\/doi.org\/10.1002\/1097-0142(19910615)67:12%3C3042::aid-cncr2820671219%3E3.0.co;2-l.","journal-title":"Cancer"},{"issue":"6","key":"4179_CR26","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.3390\/curroncol28060447","volume":"28","author":"K Chen","year":"2021","unstructured":"Chen K, Collins G, Wang H, Toh JWT. Pathological features and prognostication in colorectal cancer. Curr Oncol. 2021;28(6):5356\u201383. https:\/\/doi.org\/10.3390\/curroncol28060447.","journal-title":"Curr Oncol"},{"key":"4179_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6629060","volume":"2021","author":"SB Abegaz","year":"2021","unstructured":"Abegaz SB. Human ABO blood groups and their associations with different diseases. Biomed Res Int. 2021;2021:6629060. https:\/\/doi.org\/10.1155\/2021\/6629060.","journal-title":"Biomed Res Int"},{"issue":"5","key":"4179_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.pan.2025.06.002","volume":"25","author":"TL Correa","year":"2025","unstructured":"Correa TL, Keko M, Danielian P, Modest AM, Antunes V, Costa MC, et al. Association between ABO blood groups and pancreatic cancer outcomes: a systematic review and meta-analysis. Pancreatology. 2025;25(5):709\u201317. https:\/\/doi.org\/10.1016\/j.pan.2025.06.002.","journal-title":"Pancreatology"},{"issue":"2","key":"4179_CR29","doi-asserted-by":"publisher","first-page":"e34837","DOI":"10.7759\/cureus.34837","volume":"15","author":"ET Tuncel","year":"2023","unstructured":"Tuncel ET, Kut E. Prognostic relationship between the ABO blood groups and metastatic gastric cancer. Cureus. 2023;15(2):e34837. https:\/\/doi.org\/10.7759\/cureus.34837.","journal-title":"Cureus"},{"issue":"Suppl 1","key":"4179_CR30","doi-asserted-by":"publisher","first-page":"S268","DOI":"10.1007\/s12032-010-9735-5","volume":"28","author":"MZ Qiu","year":"2011","unstructured":"Qiu MZ, Zhang DS, Ruan DY, Luo HY, Wang ZQ, Zhou ZW, Wang FH, Li YH, Xu RH. A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China. Med Oncol. 2011;28(Suppl 1):S268\u201373. https:\/\/doi.org\/10.1007\/s12032-010-9735-5.","journal-title":"Med Oncol"},{"issue":"1","key":"4179_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"JM Pickard","year":"2017","unstructured":"Pickard JM, Zeng MY, Caruso R, N\u00fa\u00f1ez G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017;279(1):70\u201389. https:\/\/doi.org\/10.1111\/imr.12567.","journal-title":"Immunol Rev"},{"issue":"3","key":"4179_CR32","doi-asserted-by":"publisher","first-page":"e00007","DOI":"10.1128\/MMBR.00007-19","volume":"83","author":"QR Ducarmon","year":"2019","unstructured":"Ducarmon QR, Zwittink RD, Hornung BVH, van Schaik W, Young VB, Kuijper EJ. Gut microbiota and colonization resistance against bacterial enteric infection. Microbiol Mol Biol Rev. 2019;83(3):e00007\u201319.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"47","key":"4179_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036256","volume":"102","author":"G Rashid","year":"2023","unstructured":"Rashid G, Bhat GA, Rather TB, Akhtar K, Parveiz I, Ahmad SN, et al. ABO and rhesus blood group markers as predictors in colorectal cancer: a prospective observational study. Medicine (Baltimore). 2023;102(47):e36256. https:\/\/doi.org\/10.1097\/MD.0000000000036256.","journal-title":"Medicine (Baltimore)"},{"issue":"4814","key":"4179_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/bmj.1.4814.799","volume":"1","author":"I Aird","year":"1953","unstructured":"Aird I, Bentall HI-I, Fraser Roberts JA. A relationship between cancer of the stomach and the ABO blood groups. Br Med J. 1953;1(4814):799\u2013801. https:\/\/doi.org\/10.1136\/bmj.1.4814.799.","journal-title":"Br Med J"},{"issue":"3","key":"4179_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000153691","volume":"37","author":"L Beckman","year":"1987","unstructured":"Beckman L, Angqvist KA. On the mechanism behind the association between ABO blood groups and gastric carcinoma. Hum Hered. 1987;37(3):140\u20133. https:\/\/doi.org\/10.1159\/000153691.","journal-title":"Hum Hered"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04179-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:12:36Z","timestamp":1781629956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04179-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4179"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04179-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the local Ethics Committee (Comitato Etico Area Vasta Emilia Centro \u2013 CE-AVEC) under ID: 194\/2025\/Oss\/AUSLFe and was conducted in accordance with the Declaration of Helsinki. All patients included in the study signed a written informed consent before surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"92"}}